AndrewNelsonDe La TorreMDFACS, FAASLD
General Surgery • Hoboken, NJHepatobiliary Surgery, Pancreas
Director HepatoPancreatoBiliary Surgery and Liver Disease Services, Carepoint Health Associate Professor, Surgery, Rutgers-New Jersey Medical School
Dr. De La Torre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Grand St
Hoboken, NJ 07030Phone+1 201-420-7903Fax+1 201-420-7586
Summary
- Dr. Andrew de la Torre is a hepatobiliary surgeon in Hudson County NJ and is affiliated with Christ Hospital, Bayonne Medical Center, and Hoboken University Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 28 years. He specializes in laparoscopic hepatobiliary surgery, liver cancer care, and end stage liver disease. He also works on liver disease population health, and health informatics to improve early diagnosis of cancer.
Education & Training
University of MarylandFellowship, Abdominal Transplant Surgery, 1995 - 1998
Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 1990 - 1995
New York Presbyterian Hospital (Cornell Campus)Internship, Allergy and Immunology, 1989 - 1990
Johns Hopkins University School of MedicineClass of 1989
Certifications & Licensure
NJ State Medical License 1994 - 2025
NY State Medical License 2018 - 2022
MD State Medical License 1995 - 2000- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American Association for the Study of Liver disease, 2020
- Fellow American College of Surgeons
Clinical Trials
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer Start of enrollment: 2007 Oct 01
- Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Jul 01
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Publications & Presentations
PubMed
- 15 citationsA case report of donor to recipient transmission of severe thrombocytopenia purpura.Andrew N. de la Torre, Adrian C. Fisher, Dorian Wilson, Jonathan S. Harrison, Baburao Koneru
Transplantation. 2004-05-15 - 6 citationsElectronic health record year and country of birth testing and patient navigation to increase diagnosis of chronic viral hepatitisAndrew N. de la Torre, Maliha Ahmad, Farhan Ayoub, Maria Korogodsky, Norma Pichardo
Journal of Viral Hepatitis. 2019-07-01 - 71 citationsFamily physicians' knowledge and screening of chronic hepatitis and liver cancer.Jeanne M. Ferrante, Dock G. Winston, Ping-Hsin Chen, Andrew N. de la Torre
Family Medicine. 2008-05-01
Committees
- Medical Advisory Committee, American Liver Foundation 2016 - Present
Professional Memberships
- Fellow
- American Association for the Study of Liver DiseaseMember
External Links
- NJLiverSurgeryhttp://www.njliversurgery.com
- NJLiverCarehttp://www.njlivercare.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
